- Home
- SNY vs RXO Comparison
SNY vs RXO Comparison
Compare SNY & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- RXO
- Stock Information
- Founded
- SNY 1994
- RXO 2022
- Country
- SNY France
- RXO United States
- Employees
- SNY N/A
- RXO N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- RXO
- Sector
- SNY Health Care
- RXO
- Exchange
- SNY Nasdaq
- RXO Nasdaq
- Market Cap
- SNY 116.5B
- RXO 2.6B
- IPO Year
- SNY N/A
- RXO N/A
- Fundamental
- Price
- SNY $49.02
- RXO $16.76
- Analyst Decision
- SNY Buy
- RXO Hold
- Analyst Count
- SNY 2
- RXO 17
- Target Price
- SNY $62.50
- RXO $20.80
- AVG Volume (30 Days)
- SNY 2.1M
- RXO 1.8M
- Earning Date
- SNY 07-24-2025
- RXO 08-06-2025
- Dividend Yield
- SNY 3.26%
- RXO N/A
- EPS Growth
- SNY 39.56
- RXO N/A
- EPS
- SNY 5.45
- RXO N/A
- Revenue
- SNY $48,817,552,946.00
- RXO $5,070,000,000.00
- Revenue This Year
- SNY $3.39
- RXO $35.30
- Revenue Next Year
- SNY $7.05
- RXO $7.33
- P/E Ratio
- SNY $8.99
- RXO N/A
- Revenue Growth
- SNY N/A
- RXO 32.38
- 52 Week Low
- SNY $45.80
- RXO $12.19
- 52 Week High
- SNY $60.12
- RXO $32.82
- Technical
- Relative Strength Index (RSI)
- SNY 42.20
- RXO 49.34
- Support Level
- SNY $47.64
- RXO $15.44
- Resistance Level
- SNY $48.55
- RXO $16.33
- Average True Range (ATR)
- SNY 0.65
- RXO 0.61
- MACD
- SNY 0.03
- RXO -0.01
- Stochastic Oscillator
- SNY 23.48
- RXO 41.35
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.